Cargando…

Cancer Chemoprevention Using Nanotechnology-Based Approaches

Cancer research in pursuit of better diagnostic and treatment modalities has seen great advances in recent years. However, the incidence rate of cancer is still very high. Almost 40% of women and men are diagnosed with cancer during their lifetime. Such high incidence has not only resulted in high m...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Preshita, Thumma, Naga Jyothi, Wagh, Pushkaraj Rajendra, Zhan, Shuyu, Ann, David, Wang, Jeffrey, Prabhu, Sunil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146461/
https://www.ncbi.nlm.nih.gov/pubmed/32317961
http://dx.doi.org/10.3389/fphar.2020.00323
_version_ 1783520208200138752
author Desai, Preshita
Thumma, Naga Jyothi
Wagh, Pushkaraj Rajendra
Zhan, Shuyu
Ann, David
Wang, Jeffrey
Prabhu, Sunil
author_facet Desai, Preshita
Thumma, Naga Jyothi
Wagh, Pushkaraj Rajendra
Zhan, Shuyu
Ann, David
Wang, Jeffrey
Prabhu, Sunil
author_sort Desai, Preshita
collection PubMed
description Cancer research in pursuit of better diagnostic and treatment modalities has seen great advances in recent years. However, the incidence rate of cancer is still very high. Almost 40% of women and men are diagnosed with cancer during their lifetime. Such high incidence has not only resulted in high mortality but also severely compromised patient lifestyles, and added a great socioeconomic burden. In view of this, chemoprevention has gained wide attention as a method to reduce cancer incidence and its relapse after treatment. Among various stems of chemoprevention research, nanotechnology-based chemoprevention approaches have established their potential to offer better efficacy and safety. This review summarizes recent advances in nanotechnology-based chemoprevention strategies for various cancers with emphasis on lung and bronchial cancer, colorectal, pancreatic, and breast cancer and highlights the unmet needs in this developing field towards successful clinical translation.
format Online
Article
Text
id pubmed-7146461
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-71464612020-04-21 Cancer Chemoprevention Using Nanotechnology-Based Approaches Desai, Preshita Thumma, Naga Jyothi Wagh, Pushkaraj Rajendra Zhan, Shuyu Ann, David Wang, Jeffrey Prabhu, Sunil Front Pharmacol Pharmacology Cancer research in pursuit of better diagnostic and treatment modalities has seen great advances in recent years. However, the incidence rate of cancer is still very high. Almost 40% of women and men are diagnosed with cancer during their lifetime. Such high incidence has not only resulted in high mortality but also severely compromised patient lifestyles, and added a great socioeconomic burden. In view of this, chemoprevention has gained wide attention as a method to reduce cancer incidence and its relapse after treatment. Among various stems of chemoprevention research, nanotechnology-based chemoprevention approaches have established their potential to offer better efficacy and safety. This review summarizes recent advances in nanotechnology-based chemoprevention strategies for various cancers with emphasis on lung and bronchial cancer, colorectal, pancreatic, and breast cancer and highlights the unmet needs in this developing field towards successful clinical translation. Frontiers Media S.A. 2020-04-03 /pmc/articles/PMC7146461/ /pubmed/32317961 http://dx.doi.org/10.3389/fphar.2020.00323 Text en Copyright © 2020 Desai, Thumma, Wagh, Zhan, Ann, Wang and Prabhu http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Desai, Preshita
Thumma, Naga Jyothi
Wagh, Pushkaraj Rajendra
Zhan, Shuyu
Ann, David
Wang, Jeffrey
Prabhu, Sunil
Cancer Chemoprevention Using Nanotechnology-Based Approaches
title Cancer Chemoprevention Using Nanotechnology-Based Approaches
title_full Cancer Chemoprevention Using Nanotechnology-Based Approaches
title_fullStr Cancer Chemoprevention Using Nanotechnology-Based Approaches
title_full_unstemmed Cancer Chemoprevention Using Nanotechnology-Based Approaches
title_short Cancer Chemoprevention Using Nanotechnology-Based Approaches
title_sort cancer chemoprevention using nanotechnology-based approaches
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146461/
https://www.ncbi.nlm.nih.gov/pubmed/32317961
http://dx.doi.org/10.3389/fphar.2020.00323
work_keys_str_mv AT desaipreshita cancerchemopreventionusingnanotechnologybasedapproaches
AT thummanagajyothi cancerchemopreventionusingnanotechnologybasedapproaches
AT waghpushkarajrajendra cancerchemopreventionusingnanotechnologybasedapproaches
AT zhanshuyu cancerchemopreventionusingnanotechnologybasedapproaches
AT anndavid cancerchemopreventionusingnanotechnologybasedapproaches
AT wangjeffrey cancerchemopreventionusingnanotechnologybasedapproaches
AT prabhusunil cancerchemopreventionusingnanotechnologybasedapproaches